Physician profile
Stephen Charnitski
NPI 1548319676
$1,130.72
in general payments reported to CMS, 2019-2025
12 companies · $68.99 in 2025
The $68.99 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $117 · 2021: $86.43 · 2022: $471 · 2023: $47.98 · 2024: $111 · 2025: $68.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $351.80 | 2022 | |
| Align Technology, INC. | $327.04 | 2019-2025 | Invisalign |
| Orapharma, A Division of Bausch Health US, LLC | $181.42 | 2019-2024 | Arestin, Ossix Plus |
| Dentsply Sirona INC | $64.23 | 2021-2022 | |
| Kerr Corporation | $60.99 | 2022 | |
| Envista Holdings Corporation | $37.11 | 2025 | Spark |
| Philips North America LLC | $28.15 | 2021 | |
| Biohorizons Implant Systems INC. | $20.72 | 2020 | |
| 3m Company | $18.77 | 2023 | 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Filtek |
| Voco America INC. | $14.20 | 2025 | Grandio So, Meron |
| Colgate Oral Pharmaceuticals, INC. | $13.95 | 2023 | Prevident |
| Gc America INC. | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Charnitski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.